Zobrazeno 1 - 10
of 49
pro vyhledávání: '"Sulfadoxine-pyrimethamine (SP)"'
Publikováno v:
Malaria Journal, Vol 23, Iss 1, Pp 1-12 (2024)
Abstract A Stakeholder engagement meeting on the implementation of post-discharge malaria chemoprevention (PDMC) in Benin, Kenya, Malawi, and Uganda was held in Nairobi, Kenya, on 27 September 2023. Representatives from the respective National Malari
Externí odkaz:
https://doaj.org/article/52fdd7cb1b8b4945b6930f29aafe9e75
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Enesia Banda Chaponda, Sungano Mharakurwa, Charles Michelo, Jane Bruce, Daniel Chandramoha, R. Matthew Chico
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Background The World Health Organization recommends the provision of intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) at 4-week intervals from gestational week 13 to delivery in areas of moderate
Externí odkaz:
https://doaj.org/article/6eda7aea63cf4763be73da10f446055d
Autor:
Marit van Lenthe, Renske van der Meulen, Maryvonne Lassovski, Adelaide Ouabo, Edwige Bakula, Colette Badio, Deogratias Cibenda, Lucy Okell, Erwan Piriou, Lynn Grignard, Kjerstin Lanke, Bhargavi Rao, Teun Bousema, Cally Roper
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background Sulfadoxine–pyrimethamine (SP) is a cornerstone of malaria chemoprophylaxis and is considered for programmes in the Democratic Republic of Congo (DRC). However, SP efficacy is threatened by drug resistance, that is conferred by
Externí odkaz:
https://doaj.org/article/43dc475688694ee4afe33ba734387cbc
Autor:
Caroline A. Lynch, Richard Pearce, Hirva Pota, Connie Egwang, Thomas Egwang, Amit Bhasin, Jonathan Cox, Tarekegn A. Abeku, Cally Roper
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-9 (2017)
Abstract Background The I164L mutation on the dhfr gene confers high level resistance to sulfadoxine–pyrimethamine (SP) but it is rare in Africa except in a cluster of reports where prevalence >10% in highland areas of southwest Uganda and eastern
Externí odkaz:
https://doaj.org/article/9d86ec8b96b74f7ba0c516579a32104e
Autor:
Jodie Dionne-Odom, Andrew O. Westfall, Tobias O. Apinjoh, Judith Anchang-Kimbi, Eric A. Achidi, Alan T. N. Tita
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-10 (2017)
Abstract Background Malaria in pregnancy is common in sub-Saharan Africa where it contributes to perinatal morbidity and mortality. Use of insecticide-treated bed nets and intermittent preventive therapy with sulfadoxine–pyrimethamine during pregna
Externí odkaz:
https://doaj.org/article/9bbd94d18e604d4cb491dd65658d458c
Autor:
R Matthew Chico, Jane Bruce, Sungano Mharakurwa, Enesia Banda Chaponda, Charles Michelo, Daniel Chandramoha
Publikováno v:
Malaria Journal, Vol 20, Iss 1, Pp 1-10 (2021)
Malaria Journal
Malaria Journal
Background The World Health Organization recommends the provision of intermittent preventive treatment during pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) at 4-week intervals from gestational week 13 to delivery in areas of moderate to high m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66ae1bd468c21938f5f2fa2455eef921
https://doaj.org/article/6eda7aea63cf4763be73da10f446055d
https://doaj.org/article/6eda7aea63cf4763be73da10f446055d
Autor:
Maryvonne Lassovski, Renske van der Meulen, Bhargavi Rao, Colette Badio, Edwige Bakula, Teun Bousema, Lynn Grignard, Cally Roper, Marit van Lenthe, Deogratias Cibenda, Lucy C Okell, Adelaide Ouabo, Kjerstin Lanke, Erwan Piriou
Publikováno v:
Malaria Journal
Malaria Journal, 18, 1
Malaria Journal, Vol 18, Iss 1, Pp 1-9 (2019)
Malaria Journal, 18
Malar J
Malaria Journal, 18, 1
Malaria Journal, Vol 18, Iss 1, Pp 1-9 (2019)
Malaria Journal, 18
Malar J
Background Sulfadoxine–pyrimethamine (SP) is a cornerstone of malaria chemoprophylaxis and is considered for programmes in the Democratic Republic of Congo (DRC). However, SP efficacy is threatened by drug resistance, that is conferred by mutations
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::173e3f823dcbc876bbbbd7a42f1e5bdd
http://europepmc.org/articles/PMC6921399
http://europepmc.org/articles/PMC6921399
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.